$3250 | Single User
$4650 | Site License
$5650 | Global License

Nonalcoholic steatotic hepatitis (NASH) Market, By types(serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others), by application (Pharma, Hospitals, Academic Institutes) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270594 | In Stock
Related Topics: COVID , Diabetes , Pharmaceuticals

Introduction

The Nonalcoholic steatotic hepatitis (NASH) market is estimated to represent a global market of USD 3,898.6 million by 2019 with growth rate of 25.2%.

Nonalcoholic steatotic hepatitis (NASH) is the most prevalent form of progressive liver disease condition. The market is categorized into serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others. Serum biomarkers segment held the largest share of the global market, accounted for more than 40% share. Benefits such as its ability to distinguish simple steatosis from NASH offers competitive advantage over other product segments. On contrary, hepatic fibrosis biomarkers is expected to grow with highest growth rate due to rising interest of companies to invest in this product.

However, poorly suited regulatory and reimbursement guidelines pose as a threat to the global market. As per the application section, pharmaceutical industry dominated the overall market. Increasing number of pharma companies involved in research activities of NASH drugs coupled with rising number of clinical studies augments the market growth. This market segment is also expected to grow with highest CAGR owing to the rising initiatives pertaining to the development of NASH drugs.


COVID-19 Impact & Recovery Analysis

The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.

The spectrum of NAFLD & NASH is increasingly recognized both in the developed as well as developing region due to its prevalence in diabetes, insulin resistance syndrome and in obesity. North America has a well-established healthcare industry and the rising prevalence of NAFLD and NASH are expected to show a steady growth of the market during the coming years. According to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates,nearly 20% of people with NAFLD are affected by NASH.

Additionally, growing obese population coupled with increasing diabetic patients stimulate the uptake of NASH drugs hence drives the market growth. Current trends in developed regions indicated that the prevalence of obesity will cross more than 40% of the population by 2021-2027. Meanwhile, number of patients affected with diabetes is also increasing at constant rate. These would in turn provides healthy platform for the growth of NASH drugs market during the future period.

Companies such as Allergan, Intercept, Prometheus Laboratories Inc., Gilead Sciences, Galmed Pharmaceuticals, Quest Diagnostic Incorporated, Enzo Biochem, Inc. Bio-Rad Laboratories, Inc. and others are considered to be the key players of this market.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

THE NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKE,BY TYPES

Serums biomarkers

Hepatic fibrosis biomarkers

Oxidative stress biomarkers

Apoptosis biomarkers

Others

THE NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET, BY APPLICATION

Pharma

Hospitals

Academic Institutes

others

THE NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET,BY REGION

North America

Europe

Asia Pacific

Rest of the World

Table of Contents
for Nonalcoholic steatotic hepatitis (NASH) Market, By types(serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others), by application (Pharma, Hospitals, Academic Institutes) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET OVERVIEW

    Study Scope

    Base Year

    Assumption and Methodology

    EXECUTIVE SUMMARY

    Key Market Facts

    Geographical Scenario

    Companies in the Market

    NONALCOHOLIC STEATOTIC HEPATITIS (NASH) KEY MARKET TRENDS

    Market Drivers

    Impact Analysis of Market Drivers

    Market Restraints

    Impact Analysis of Market Restraints

    Market Opportunities

    Market Future Trends

    NONALCOHOLIC STEATOTIC HEPATITIS (NASH) INDUSTRY STUDY

    Company Activity Analysis

    Regulatory Framework Analysis

    Value Chain Analysis

    NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET LANDSCAPE

    Market Share Analysis

    Key Innovators

    NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET – BY TYPES:

    Overview

    Serums Biomarkers

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Hepatic Fibrosis Biomarkers

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Oxidative Stress Biomarkers

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Apoptosis biomarkers

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Others

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET – BY APPLICATION:

    Overview

    Pharma

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Hospitals

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Academic Institutes

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Others

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    NONALCOHOLIC STEATOTIC HEPATITIS (NASH) MARKET– BY GEOGRAPHY

    Introduction

    North America

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    S.

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Canada

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Europe

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    France

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Germany

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of Europe

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Asia Pacific (APAC)

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    China

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    India

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of APAC

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Rest of the World

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Latin America

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    Middle East and Africa

    Overview

    Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    KEY VENDOR ANALYSIS

    Allergan

    Company Overview

    SWOT Analysis

    Key Developments

    Intercept

    Company Overview

    SWOT Analysis

    Key Developments

    Prometheus Laboratories Inc.

    Company Overview

    SWOT Analysis

    Key Developments

    Gilead Sciences

    Company Overview

    SWOT Analysis

    Key Developments

    Galmed Pharmaceuticals

    Company Overview

    SWOT Analysis

    Key Developments

    Quest Diagnostic Incorporated

    Company Overview

    SWOT Analysis

    Key Developments

    Enzo Biochem, Inc.

    Company Overview

    SWOT Analysis

    Key Developments

    Bio-Rad Laboratories, Inc.

    Company Overview

    SWOT Analysis

    Key Developments

    360 DEGREE ANALYSTVIEW

    APPENDIX

    Research Methodology

    Abbreviations

    Disclaimer

    Contact Us

    SCOPE AND OBJECTIVES

    The objective of this report is to describe the market trends and revenue forecasts for the NONALCOHOLIC STEATOTIC HEPATITIS (NASH) Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

    The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the NONALCOHOLIC STEATOTIC HEPATITIS (NASH) Market by its major segments, which include the type, end user industry, and the major geographic regions.

    KEY BENEFITS OF THE REPORT:

    Understanding of the strategies that are being adopted by the key players in this market to stay competitive

    Extensive analysis of the key players dominating the competitive landscape of this market

    In-depth analysis of the key factors are propelling the growth of the global market

    Detailed analysis of the geographic region that will witness the strongest growth

    Granular analysis of the current market scenario and the expected market grow

List Of Tables
in Nonalcoholic steatotic hepatitis (NASH) Market, By types(serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others), by application (Pharma, Hospitals, Academic Institutes) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2014 - 2025

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PESTLE Analysis

Table 7 Porter's Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Nonalcoholic Steatotic Hepatitis (NASH) Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

Figure 10 Nonalcoholic Steatotic Hepatitis (NASH) Market, by Types, 2016 – 2027 (USD Million)

Figure 11 Nonalcoholic Steatotic Hepatitis (NASH) Market, by Application, 2016 – 2027 (USD Million)

Figure 12 Nonalcoholic Steatotic Hepatitis (NASH) Market, by Geography, 2016 – 2027 (USD Million)

Table 13 North America Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 14 U.S. Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 15 Canada Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 16 Europe Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 17 France Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 18 Germany Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 19 Asia Pacific Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 20 China Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 21 India Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 22 Latin America Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

Table 23 MEA Nonalcoholic Steatotic Hepatitis (NASH) Market, 2016 – 2027 (USD Million)

List Of Figures, Charts and Diagrams
in Nonalcoholic steatotic hepatitis (NASH) Market, By types(serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others), by application (Pharma, Hospitals, Academic Institutes) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methdology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Value Chain Analysis Analysis

Figure 6 Nonalcoholic Steatotic Hepatitis (NASH) Market, by Types, 2016 – 2027 (USD Million)

Figure 6 Nonalcoholic Steatotic Hepatitis (NASH) Market, by Application, 2016 – 2027 (USD Million)

Figure 7 Nonalcoholic Steatotic Hepatitis (NASH) Market, by Geography, 2016 – 2027 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270594 | AV126

Number of Pages

230

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market
Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific ...
03 Dec 2018 by GBI Research USD $4,995 More Info
Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast To 2023
DelveInsight “Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast To 2023” provides an overv...
31 May 2017 by Delve Insight USD $2,750 More Info
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete.DelveInsight’s Nonalcoholic Steatohepatiti...
30 May 2017 by Delve Insight USD $4,950 More Info
Global Nonalcoholic Fatty Liver Disease Market Research Report Forecast 2017 to 2021
The Global Nonalcoholic Fatty Liver Disease Market Research Report Forecast 2017-2021 is a valuable ...
15 May 2017 by S&P Consulting USD $2,800 More Info
Nonalcoholic Drinks Market by Product Type (Soft Drinks, Bottled Water, Tea & Coffee, Juice, Dairy Drinks, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Nonalcoholic drinks, also known as ‘virgin drinks’, ‘mocktails’ and ‘n...
20 Dec 2016 by Allied Market Research USD $5,370 More Info
Nonalcoholic Drinks Market by Product Type (Soft Drinks, Bottled Water, Tea & Coffee, Juice, Dairy Drinks, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Nonalcoholic drinks, also known as ‘virgin drinks’, ‘mocktails’ and ‘near beer’, refer to the bevera...
01 Dec 2016 by Allied Market Research USD $4,740 More Info
Nonalcoholic Drinks Market by Product Type (Soft Drinks, Bottled Water, Tea & Coffee, Juice, Dairy Drinks, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Nonalcoholic drinks, also known as ‘virgin drinks’, ‘mocktails’ and ‘near beer’, refer to the bevera...
01 Dec 2016 by Allied Market Research USD $5,370 More Info
Nonalcoholic Steatohepatitis (NASH): KOL Insight
IntroductionWho will benefit most from huge opportunities in NASH treatment?The first new NASH thera...
01 May 2016 by FirstWord Pharma USD $7,900 More Info
Nonalcoholic Steatohepatitis (NASH): KOL Insight
Who will benefit most from huge opportunities in NASH treatment?The first new NASH therapy is due so...
01 May 2016 by FirstWord Pharma USD $7,900 More Info
Nonalcoholic Steatohepatitis: KOL Insight
IntroductionWhy This Report is Essential Expect a revolution in the treatment of nonalcoholic steato...
01 Mar 2015 by FirstWord Pharma USD $7,900 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Nonalcoholic steatotic hepatitis (NASH) Market, By types(serums biomarkers, Hepatic fibrosis biomarkers, Oxidative stress biomarkers, Apoptosis biomarkers, and others), by application (Pharma, Hospitals, Academic Institutes) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...